NU Skin Enterprises Inc. Class A (NUS)

CONSUMER STAPLES: PERSONAL PRODUCTS
SIC: WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

75 WEST CENTER ST PROVO, UT 84601

NU Skin Enterprises is a direct selling company with operations in 52 markets worldwide. Co. develops and distributes personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively. Co.'s Nu Skin product line by category includes: core systems; targeted treatments; total care; cosmetic; and Epoch. Co.'s Pharmanex product line by category includes: nutritional; anti-aging, solutions; weight management; and Vitameal. In addition, Co. provides a limited number of other products and services, including household products and digital content storage. Co. sells its products to a network of independent distributors, except its operations in Mainland China.

Data based on most recent fiscal year report
Market Cap3.898 Billion Shares Outstanding52.6 Million Avg Volume959.351 Thousand
1-Yr BETA vs S&P TR0.961 Current Ratio1.74 Quick Ratio1.17
View SEC Filings from NUS instead.
Q2 2019 All Institutions Hedge Funds 1
To trade NUS now:
Filers who had this stock in their top 10: 4 2 (0.21%)
13F Filers holding this stock: 253 35 (3.62%)
Aggregate 13F shares on 06/30/2019: 40.806 Million 8.126 Million
Aggregate 13F shares on 03/31/2019: 42.846 Million 6.333 Million
Percent change: -4.76% 28.30%
Funds creating new positions: 43 10
Funds Adding to an existing position: 91 13
Funds closing out their position: 55 14
Funds reducing their position: 80 8
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NUS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

THOMAS JAMES D CHIEF ACCOUNTING OFFICER

  • Officer
3,810 2019-08-01 1

WOODBURY EDWINA D

  • Director
9,770 2019-06-12 5

THOMAS PISANO R.

  • Director
47,356 2019-06-06 1

CAMPBELL DANIEL W

  • Director
72,190 2019-06-06 2

LIPMAN ANDREW D

  • Director
69,100 2019-06-06 4

SHEN ZHEQING

  • Director
8,375 2019-06-06 1

NATHANSON LAURA

  • Director
2,878 2019-06-06 2

OFFEN NEIL H

  • Director
10,083 2019-05-21 1

ANDERSEN NEVIN N

  • Director
34,045 2019-05-21 3

CHANG JOSEPH Y CHIEF SCIENTIFIC OFFICER

  • Officer
129,408 2019-03-04 4

WOOD RITCH N CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
147,329 2019-03-04 4

DORNY D MATTHEW GENERAL COUNSEL

  • Officer
37,241 2019-03-04 10

NAPIERSKI RYAN S PRESIDENT

  • Officer
73,713 2019-03-04 4

LAWRENCE MARK H CHIEF FINANCIAL OFFICER

  • Officer
43,414 2019-03-02 3

CHARD DANIEL R CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
20,777 2019-02-20 0

LUND STEVEN EXEC. CHAIRMAN OF THE BOARD

  • Officer
  • Director
285,218 2018-12-31 1

PING AN ZQ CHINA GROWTH OPPORTUNITY LTD

SHEN ZHEQING

  • Director
0 2018-03-07 1

SHEN ZHEQUING

  • Director
3,456 2017-05-11 0

HUNT M TRUMAN PRESIDENT & CEO

  • Officer
  • Director
0 2017-02-27 0

SCHWERDT SCOTT E PRESIDENT, AMERICAS REGION

  • Officer
0 2015-12-18 0

NEGRON PATRICIA

  • Director
No longer subject to file 2015-05-13 0

GARN EJ JAKE

  • Director
No longer subject to file 2013-02-21 0

TILLOTSON SANDRA

  • Director
3,160,845 2012-05-04 0

USSERY DAVID D.

  • Director
13,222 2012-02-09 0

RONEY BLAKE CHAIRMAN OF THE BOARD

  • Officer
  • Director
  • 10% Owner
3,716,458 2011-04-12 0

PAHWA ASHOK CHIEF MARKETING OFFICER

  • Officer
3,322 2009-08-28 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments